Max Robotics — Global Service Robot Directory + US Certification

About

Xingqi Zhang is a leading surgical oncologist specializing in minimally invasive gastric cancer surgery, with a focus on enhancing postoperative recovery and refining operative techniques. Their major contributions include pioneering research on early dietary interventions, such as a landmark randomized controlled trial demonstrating that drinking Chinese green tea after subtotal distal gastrectomy safely reduces postoperative ileus and improves short-term outcomes (25 citations). Zhang has also advanced the field through high-volume center studies comparing robotic and laparoscopic total gastrectomy, showing that robotic approaches offer superior intraoperative performance and comparable long-term outcomes (19 citations). Further, they have integrated preoperative perigastric artery CTA into surgical decision-making, enabling more precise vessel dissection and improved short- and long-term results in radical gastrectomy (7 citations). With over 50 cumulative citations, Zhang’s work is shaping evidence-based protocols for enhanced recovery after surgery (ERAS) and the adoption of robotic platforms in gastric cancer care. Their research is widely cited by gastrointestinal surgeons and has been presented at international conferences, underscoring its impact on clinical practice and patient outcomes.